DNA aptamers that modulate biological activity of model neurons

There is an urgent need for agents that promote health and regeneration of cells and tissues, specifically to treat diseases of the aging nervous system. Age-associated nervous system degeneration and various diseases are driven by many different biochemical stresses, often making it difficult to target any one disease cause. Our laboratory has previously identified DNA aptamers with apparent regenerative properties in murine models of multiple sclerosis by selecting aptamers that bind oligodendrocyte membrane preparations. Here, we selected from vast libraries of molecules (∼10<sup>14</sup> unique DNAs) those with the ability to bind cultured human SH-SY5Y neuroblastoma cells as a neuronal model, followed by screening for aptamers capable of eliciting biological responses, with validation of binding in differentiated SH-SY5Y, human induced pluripotent stem cell (iPSC)-derived sensory neurons, and human embryonic stem cell (hESC)-derived cortical neurons. This demonstrates a proof-of-concept workflow to identify biologically active aptamers by cycles of cell selection.

Authors

Institutions

Publication Details

Journal
Molecular Therapy — Nucleic Acids
Published
2024-11-15
DOI
https://doi.org/10.1016/j.omtn.2024.102392
Citations
1
Primary Topic
Advanced biosensing and bioanalysis techniques
Type
article
Field-Weighted Citation Impact
0.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DNA aptamers that modulate biological activity of model neurons

Keenan S. Pearson, Sybil Hrstka, Andrew P. Minotti, Brandon Wilbanks et al.
1 citations
Molecular Therapy — Nucleic Acids
Advanced biosensing and bioanalysis techniques
0.23
article

DNA aptamers that modulate biological activity of model neurons

Keenan S. Pearson, Sybil Hrstka, Andrew P. Minotti, Brandon Wilbanks, Arthur E. Warrington, L. James Maher, Lorenz Studer, Nathan P. Staff, Jenelle Rolli
article en
1 citations

Abstract

There is an urgent need for agents that promote health and regeneration of cells and tissues, specifically to treat diseases of the aging nervous system. Age-associated nervous system degeneration and various diseases are driven by many different biochemical stresses, often making it difficult to target any one disease cause. Our laboratory has previously identified DNA aptamers with apparent regenerative properties in murine models of multiple sclerosis by selecting aptamers that bind oligodendrocyte membrane preparations. Here, we selected from vast libraries of molecules (∼10<sup>14</sup> unique DNAs) those with the ability to bind cultured human SH-SY5Y neuroblastoma cells as a neuronal model, followed by screening for aptamers capable of eliciting biological responses, with validation of binding in differentiated SH-SY5Y, human induced pluripotent stem cell (iPSC)-derived sensory neurons, and human embryonic stem cell (hESC)-derived cortical neurons. This demonstrates a proof-of-concept workflow to identify biologically active aptamers by cycles of cell selection.

Molecular Therapy — Nucleic AcidsVol. 35(4)
Mayo Clinic (US), Cornell University (US), WinnMed (US), Kettering University (US), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)
National Science Foundation, U.S. Department of Defense, Mayo Clinic, National Sleep Foundation, National Institutes of Health
Zero hunger
Openalex Percentile: Top 41%
Advanced biosensing and bioanalysis techniques
0.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.